Classification of risk for transmission of vaccine-preventable diseases in Brazilian municipalities: comparative analysis before and after the national movement for vaccination and multivaccination proposed by the Ministry of Health as of 2023.

Publication date: Feb 08, 2025

To analyze the classification of the risk of transmission of vaccine-preventable diseases in Brazilian municipalities before and after the National Movement for Vaccination and Multivaccination proposed by the Ministry of Health. This is an epidemiological, ecological study using secondary data on vaccination coverage, dropout rates, and homogeneity of vaccination coverage (HCV) for ten immunobiologicals recommended for children under 2 years of age. The study aims to compare the years 2022 and 2023 in Brazil. The vaccination coverage index (VCI), HCV, and dropout rate (DR) were evaluated in the municipalities of Brazil in the years 2022 and 2023. The municipalities were classified into risk strata for transmission of vaccine-preventable diseases before and after the strategy proposed by the Ministry of Health. The study found an increase in median vaccination coverage (VC) for all vaccines evaluated, except for the varicella vaccine. Regarding HCV, in 2022, 27. 99% of Brazilian municipalities were classified as adequate (≥ 70%), and 410 (7. 36%) achieved 100% HCV for all vaccines. In 2023, 34. 90% of municipalities were classified as adequate (≥ 70%), and among them, 582 (10. 46%) achieved 100% HCV for all vaccines. In terms of the risk classification for the transmission of vaccine-preventable diseases, Brazil had 72. 01% of municipalities classified as high or very high risk in 2022, which decreased to 65. 13% in 2023. As for municipalities classified as low or very low risk, 11. 27% fell into this category in 2022, increasing to 18. 12% in 2023. The study concludes that VC surveillance, in conjunction with the Microplanning for High-Quality Vaccination Activities methodology developed by the Ministry of Health in 2023, played a crucial role in resuming immunization efforts that had been hindered by science denialism and the COVID-19 pandemic.

Open Access PDF

Concepts Keywords
Brazil Brazil
Dropout Cities
Vaccine Humans
Immunization Programs
Infant
Monitoring
Risk Assessment
Risk management
Surveillance
Vaccination
Vaccination Coverage
Vaccination coverage
Vaccine-Preventable Diseases
Vaccine-preventable diseases

Semantics

Type Source Name
disease MESH vaccine-preventable diseases
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Varicella Zoster Vaccine (Live/Attenuated)
disease IDO quality
disease IDO role
disease MESH COVID-19 pandemic
pathway REACTOME Reproduction
drug DRUGBANK Coenzyme M
disease MESH complications
disease MESH smallpox
disease MESH measles
pathway KEGG Measles
disease MESH polio
disease IDO country
disease MESH causes
drug DRUGBANK Trestolone
drug DRUGBANK Aspartame
disease MESH diphtheria
drug DRUGBANK Triethylenetetramine
disease MESH pertussis
pathway KEGG Pertussis
disease MESH hepatitis
disease MESH mumps
disease MESH rubella
drug DRUGBANK BCG vaccine
drug DRUGBANK Yellow Fever Vaccine
drug DRUGBANK Rotavirus Vaccine

Original Article

(Visited 2 times, 1 visits today)